Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

NIH Funding Component of 21st Century Cures May Get White House Boost

Executive Summary

Vice President’s Cancer Moonshot project could provide final thrust for '21st Century Cures' bill in the lame duck Congressional session after election.

Advertisement

Related Content

The Unlikely Savior Of 21st Century Cures: Donald Trump
The Unlikely Savior Of ‘21st Century Cures’ Is Donald Trump
Regenerative Medicine In Cures: Conditional Approval Dropped In Lieu Of ‘Breakthrough’-Style Approach
Clinical Trial Disclosure Rule Warns Of Legal Penalties For Failure To Submit
Quest For Political Capital, Legacy Could Push 'Cures' Over The Finish Line
FDA's Pazdur Won't Become Oncology Bureaucrat: 'My Presence Will Be Felt'
Regulating Cell Therapies: Conditional Approval Under Consideration In Congress; FDA Plans Public Hearing
New US Compassionate Use Tool Would Need Support Of Drug Makers

Topics

Advertisement
UsernamePublicRestriction

Register